Nexalin’s CEO Mark White to be Interviewed Live on “The Big Biz Show” Today at 3PM Eastern Time
August 03 2023 - 8:30AM
Nexalin Technology, Inc. (the “Company” or “Nexalin”)
(Nasdaq: NXL; NXLIW) today announced that its Chief
Executive Officer, Mark White, will be participating in a live
interview with the “Big Biz Show,” an Emmy Award-winning nationally
syndicated TV and radio show today, Thursday, August 3rd, 2023 at
3:00 PM ET.
Mark White, CEO of Nexalin Technology, Inc.,
stated, “I am very excited to discuss recent developments and
upcoming milestones regarding our non-invasive, frequency-based,
deep-brain stimulation medical devices for treating mental health
and addiction disorders. I look forward to speaking with Bob
Sullivan and Mike Costa and all The Big Biz Shows listeners.”
The interview will be aired on cable TV and
streaming services, including Roku, as well as on radio via The Biz
Talk Radio Network, Armed Forces Radio, and iHeart Media in 175
countries.
Podcasts of the show will be available on iHeart
Radio, Apple Podcasts, Speaker.com, and TuneIn, as well as to
subscribers of biztv.com or ytaclub.com.
About the Big Biz ShowWidely regarded as
"Business with a Bite," the Big Biz Show is an Emmy Award-winning
nationally syndicated radio and TV program. The fast-talking,
hard-hitting show is hosted by Bob "Sully" Sullivan, who is also a
weekly contributor on the FOX Business Network. For more
information, go to bigbizshow.com.
About Nexalin Technology, Inc.Nexalin
designs and develops innovative neurostimulation products to
uniquely and effectively help combat the ongoing global mental
health epidemic. All of Nexalin’s products are non-invasive and
undetectable to the human body and developed to provide relief to
those afflicted with mental health issues. Nexalin utilizes
bioelectronic medical technology to treat mental health issues.
Nexalin believes its neurostimulation medical devices can penetrate
structures deep in the mid-brain that are associated with mental
health disorders. Nexalin believes the deeper penetrating waveform
in its next-generation devices will generate enhanced patient
response without any adverse side effects. The Nexalin Gen-2 15
milliamp (mA) neurostimulation device was recently approved in
China by the National Medical Products Administration (NMPA) for
the treatment of insomnia and depression. Additional information
about the Company is available at: https://nexalin.com/.
FORWARD-LOOKING STATEMENTSThis press release
contains statements that constitute "forward-looking statements,"
These statements relate to future events or Nexalin’s future
financial performance. Any statements that refer to expectations,
projections or other characterizations of future events or
circumstances or that are not statements of historical fact
(including without limitation statements to the effect that Nexalin
or its management “believes”, “expects”, “anticipates”, “plans”,
“intends” and similar expressions) should be considered forward
looking statements that involve risks and uncertainties which could
cause actual events or Nexalin’s actual results to differ
materially from those indicated by the forward-looking
statements. Forward-looking statements are subject to
numerous conditions, many of which are beyond the control of the
Company, including those set forth in the Risk Factors section of
the Company's Report on Form 10-K for the year ended December 31,
2022 and other filings as filed with the Securities and Exchange
Commission. Copies of such filings are available on the SEC's
website, www.sec.gov. Such forward-looking statements are made as
of the date hereof and may become outdated over time. Such
forward-looking statements are made as of the date hereof and may
become outdated over time. The Company undertakes no obligation to
update these statements for revisions or changes after the date of
this release, except as required by law.
Contact:Crescendo Communications, LLCTel: (212)
671-1020Email: NXL@crescendo-ir.com
Nexalin Technologies (NASDAQ:NXLIW)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nexalin Technologies (NASDAQ:NXLIW)
Historical Stock Chart
From Sep 2023 to Sep 2024